ArticleHaematologica2023

Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.

Hiroyuki Takamatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.